Pediatric Oncology

The FDA approved nivolumab as adjuvant treatment of adult and pediatric patients 12 years and older with completely resected stage IIB or IIC melanoma, according to the agent’s manufacturer.

Pediatric patients undergoing treatment with radiation therapy often have difficulty tolerating the process of daily treatment.

Despite increased interest in use of medical cannabis to alleviate cancer symptoms, there is limited rigorous evidence about the efficacy and safety of these products for pediatric patients, a systematic review and meta-analysis showed.

Damon Reed, MD, has been appointed inaugural head of the division of pediatric solid tumors at Memorial Sloan Kettering Cancer Center.

A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving heart health of childhood cancer survivors, according to results of a multicenter phase 2b trial.

A functional precision medicine-guided approach appeared to increase PFS among a small cohort of pediatric patients with recurrent and/or refractory solid and hematologic cancers, according to results of a prospective study.

A partnership between health care systems along the U.S.-Mexico border led to clinically meaningful improvement in survival outcomes among children with acute lymphoblastic leukemia, study results showed.

Bereaved parents prioritized satisfactory symptom management above all other aspects of end-of-life care for their children who died of cancer, study results showed.

An expert panel of pediatric cardiologists and oncologists issued its inaugural cardio-oncology guidelines for the management of pediatric patients receiving anticancer therapy.

Childhood, adolescent and young adult survivors of bone and soft tissue sarcomas had an increased risk for second malignant neoplasms, according to study results in Cancer.